CO5090854A1 - Recipiente que contiene formulaciones parenterales de 5h- dibenz (b,f)azepin-5-carboxamidas utiles en el tratamiento de ataques epilepticos - Google Patents

Recipiente que contiene formulaciones parenterales de 5h- dibenz (b,f)azepin-5-carboxamidas utiles en el tratamiento de ataques epilepticos

Info

Publication number
CO5090854A1
CO5090854A1 CO98057677D CO98057677D CO5090854A1 CO 5090854 A1 CO5090854 A1 CO 5090854A1 CO 98057677 D CO98057677 D CO 98057677D CO 98057677 D CO98057677 D CO 98057677D CO 5090854 A1 CO5090854 A1 CO 5090854A1
Authority
CO
Colombia
Prior art keywords
dibenz
carboxamids
azepin
useful
treatment
Prior art date
Application number
CO98057677D
Other languages
English (en)
Spanish (es)
Inventor
Peter Van Hoogevest
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO5090854A1 publication Critical patent/CO5090854A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CO98057677D 1997-10-09 1998-10-05 Recipiente que contiene formulaciones parenterales de 5h- dibenz (b,f)azepin-5-carboxamidas utiles en el tratamiento de ataques epilepticos CO5090854A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721497.7A GB9721497D0 (en) 1997-10-09 1997-10-09 Organic compounds

Publications (1)

Publication Number Publication Date
CO5090854A1 true CO5090854A1 (es) 2001-10-30

Family

ID=10820342

Family Applications (2)

Application Number Title Priority Date Filing Date
CO98057677D CO5090854A1 (es) 1997-10-09 1998-10-05 Recipiente que contiene formulaciones parenterales de 5h- dibenz (b,f)azepin-5-carboxamidas utiles en el tratamiento de ataques epilepticos
CO98057677A CO4950520A1 (es) 1997-10-09 1998-10-05 Formulaciones parenterales de 5h-dibenz (b,f) azepin-5- carboxiamidas utiles en el tratamiento de ataques epilepti- cos

Family Applications After (1)

Application Number Title Priority Date Filing Date
CO98057677A CO4950520A1 (es) 1997-10-09 1998-10-05 Formulaciones parenterales de 5h-dibenz (b,f) azepin-5- carboxiamidas utiles en el tratamiento de ataques epilepti- cos

Country Status (31)

Country Link
US (2) US6316417B1 (https=)
EP (1) EP1033988B1 (https=)
JP (2) JP2001519395A (https=)
KR (1) KR100760326B1 (https=)
CN (1) CN1210032C (https=)
AR (1) AR015465A1 (https=)
AT (1) ATE257383T1 (https=)
AU (1) AU748034B2 (https=)
BR (1) BR9812861A (https=)
CA (1) CA2304661C (https=)
CO (2) CO5090854A1 (https=)
CZ (1) CZ298900B6 (https=)
DE (1) DE69821024T2 (https=)
DK (1) DK1033988T3 (https=)
ES (1) ES2214738T3 (https=)
GB (1) GB9721497D0 (https=)
HU (1) HU226106B1 (https=)
ID (1) ID24134A (https=)
IL (1) IL135123A0 (https=)
MY (1) MY122129A (https=)
NO (1) NO327263B1 (https=)
NZ (1) NZ503526A (https=)
PE (1) PE121998A1 (https=)
PL (1) PL192287B1 (https=)
PT (1) PT1033988E (https=)
RU (1) RU2242231C2 (https=)
SK (1) SK286253B6 (https=)
TR (1) TR200000870T2 (https=)
TW (1) TW584563B (https=)
WO (1) WO1999018966A1 (https=)
ZA (1) ZA989183B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US20100204178A1 (en) 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
BRPI0616447A2 (pt) * 2005-09-30 2011-06-21 Ovation Pharmaceuticals Inc complexo de inclusão de carbamazepina-ciclodextrina, método de administrar e método de preparar o mesmo
KR20140093764A (ko) * 2006-02-09 2014-07-28 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CN101711739B (zh) * 2008-10-08 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 卡马西平的口服药物组合物
CN105726466A (zh) * 2014-12-10 2016-07-06 辽宁药联制药有限公司 一种奥卡西平注射剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202311A (en) * 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
ES2081965T3 (es) * 1989-12-27 1996-03-16 Ciba Geigy Ag Dispositivo para homogenizar la distribuccion no homogenea de la luz de un haz de rayos laser.
EP0435826A1 (de) * 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
RU2020972C1 (ru) * 1991-02-07 1994-10-15 Мегдятов Рашид Салехович Способ лечения невралгии тройничного нерва
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2702148B1 (fr) 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine

Also Published As

Publication number Publication date
CZ20001279A3 (cs) 2000-07-12
KR20010072533A (ko) 2001-07-31
WO1999018966A1 (en) 1999-04-22
NO20001730L (no) 2000-04-04
CN1274286A (zh) 2000-11-22
HUP0004362A3 (en) 2006-06-28
DE69821024D1 (de) 2004-02-12
DE69821024T2 (de) 2004-10-28
ZA989183B (en) 1999-04-09
TR200000870T2 (tr) 2000-10-23
US20020055503A1 (en) 2002-05-09
EP1033988A1 (en) 2000-09-13
ID24134A (id) 2000-07-06
HU226106B1 (en) 2008-04-28
JP2005281314A (ja) 2005-10-13
NZ503526A (en) 2003-01-31
SK5052000A3 (en) 2000-12-11
PT1033988E (pt) 2004-05-31
KR100760326B1 (ko) 2007-09-20
NO20001730D0 (no) 2000-04-04
AU748034B2 (en) 2002-05-30
GB9721497D0 (en) 1997-12-10
CZ298900B6 (cs) 2008-03-05
PL192287B1 (pl) 2006-09-29
ATE257383T1 (de) 2004-01-15
AU9629898A (en) 1999-05-03
IL135123A0 (en) 2001-05-20
BR9812861A (pt) 2000-08-08
RU2242231C2 (ru) 2004-12-20
MY122129A (en) 2006-03-31
CA2304661A1 (en) 1999-04-22
US6316417B1 (en) 2001-11-13
JP2001519395A (ja) 2001-10-23
HUP0004362A2 (hu) 2001-08-28
PL339446A1 (en) 2000-12-18
EP1033988B1 (en) 2004-01-07
HK1031824A1 (en) 2001-06-29
PE121998A1 (es) 1999-12-08
CO4950520A1 (es) 2000-09-01
CN1210032C (zh) 2005-07-13
AR015465A1 (es) 2001-05-02
SK286253B6 (sk) 2008-06-06
TW584563B (en) 2004-04-21
ES2214738T3 (es) 2004-09-16
US6458770B1 (en) 2002-10-01
NO327263B1 (no) 2009-05-25
CA2304661C (en) 2007-12-11
DK1033988T3 (da) 2004-04-13

Similar Documents

Publication Publication Date Title
ES2101503T3 (es) Formulaciones cosmeticas y dermatologicas de proteccion a la luz que contienen micropigmentos inorganicos.
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
NO305904B1 (no) Benzazepin-, benzoksazepin- og benzotiazepin-N-eddiksyre-derivater, samt legemiddel inneholdende disse forbindelser
BG104392A (en) Methods for the modulation of serin/treonin protein kinase function with compounds based on 5-azaquinoxaline
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
MY107158A (en) 3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
ES2176729T3 (es) Purificacion de 1,1,1,3,3-pentafluoropropano (r-245fa).
IT1302347B1 (it) Procedimento per la produzione diretta di perossido di idrogeno.
IL142876A0 (en) Nano-emulsion of 5-aminolevulinic acid
CA2043033A1 (fr) Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine
EP0652924A4 (en) Peroxy bleaching composition stabilized with ethylenediamine-n,n'-disuccinic acid.
EA200400259A1 (ru) Дезинфицирующий раствор на основе гипохлорита натрия и способ его получения
CA2270177A1 (en) Transdermal administration of ment
CO5090854A1 (es) Recipiente que contiene formulaciones parenterales de 5h- dibenz (b,f)azepin-5-carboxamidas utiles en el tratamiento de ataques epilepticos
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
EP0666307A3 (en) Packaged liquid bleach composition.
EP0673638A3 (en) Cosmetic composition containing antibodies.
UY26494A1 (es) " estabilización de vino"
BR0012553A (pt) Pastilhas contendo ambroxol
DK0586666T4 (da) Brugeraktiveret iontoforetisk indretning
EA199900963A1 (ru) Лекарственные формы сертралина в виде раствора, заключенного в желатиновые капсулы
GB9906458D0 (en) Compound
GR3030026T3 (en) Stabilised pharmaceutical compositions containing dobutamine
BR0207953A (pt) Derivados de caloporosida, processos para a sua preparação e sua aplicação